Solanum Medical Communications. Fair balance, transparency, good practice, trust and reliability: The cornerstones of "doing the right thing" for patients
#OpenAccess (OA) to research published by pharmaceutical companies can improve transparency and foster trust. Being able to benchmark companies is an important step. Proud to be amongst the frontrunners in OA! #PioneeringForPatients#ISMPPAnnual2022
Fake covid vaccines boost the black market for counterfeit medicines bmj.com/content/375/bmj.n275…
I guess it was only a matter of time before this started to happen......
Predatory publishers’ latest scam: bootlegged and rebranded papers nature.com/articles/d41586-0…
Like with the Hydra, you can chop off some of the tentacles but the beast keeps going!
Henrietta Lacks, Whose Cells Were Taken Without Her Consent, Is Honoured by The WHO. nytimes.com/2021/10/13/scien…
Read this NYT article and the book by Rebecca Skloot "The Immortal Life of Henrietta Lacks" if you have ever been involved with oncology or biomedical sciences.
Despite significant scientific progress in the understanding of chronic inflammatory diseases, patients continue to face challenges in holistically controlling their #IBD. We listen to patients to better understand ongoing areas of need to inform our research.
Clinical trial transparency and data sharing among biopharmaceutical companies and the role of company size, location and product type: a cross-sectional descriptive analysis @BMJ_Openbmjopen.bmj.com/content/11/7…
Register now for the 9th EMWA Symposium day: "Clinical Trials - New Trends"
Date: 6 May 2021
Open to members and non-members
virtual2021.emwa.org/symposi…